Table of Content

Analysis Highlights
Key Market Highlights
Top Asia-Pacific Pharmaceutical Industry Predictions for 2023
Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Asia-Pacific Pharmaceutical Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Environment
Market Segmentation
Market Segmentation
Key Market Themes
Growth Environment
Growth Environment (continued)
Growth Environment (continued)
Growth Environment (continued)
Key Trend 1: Precision Medicine
Key Trend 1: Precision Medicine (continued)
Key Trend 2: Digitization in Health and Pharma
Key Trend 2: Digitization in Health and Pharma (continued)
Key Trend 3: Patient-centric Care
Key Trend 3: Patient-centric Care (continued)
Key Trend 4: Anti-microbial Resistance (AMR)
Key Trend 4: Anti-microbial Resistance (AMR) (continued)
Macroeconomic Factors
Top 5 Global Economic Highlights of 2023
Global GDP Growth Snapshot
Advanced Economy Predictions for 2023
Emerging Market Economy Predictions for 2023
2023 Regional Risks and Policy Direction
Inflation: Impact Analysis
Inflation: Impact Analysis (continued)
Sustainability Initiatives: Impact Analysis
Sustainability Initiatives: Impact Analysis (continued)
Supply Chain Disruptions: Impact Analysis
Supply Chain Disruptions: Impact Analysis (continued)
Revenue Trends
Revenue Forecast by Country
Revenue Forecast by Country (continued)
Market Snapshot, 2022
Revenue Forecast by Segments: Innovators vs Generics
2022 Market Snapshot: Innovators
2022 Market Snapshot: Generics
Market Snapshot: Companies to Watch
Market Snapshot: Companies to Watch (continued)
Asia-Pacific Pharma Predictions, 2023
Prediction 1: Driven by Emerging Southeast Asian Markets, Asia-Pacific will Dominate Clinical Trial Outsourcing with >16% Growth in 2023
Prediction 2: Small to Mid-segment Pharma Investments in Japan and >30 Korean Biopharma Setups in the United States are Expected to Spur Advanced Therapy Pipelines
Prediction 3: Domestic Emerging Biopharma Companies are Forecast to Contribute to >85% of the Total Clinical Pipelines in China in 2023
Prediction 4: API Unicorns to Rise in India Under the Production Linked Incentive (PLI) Schemes Attracting an Estimated $60 Million+ Investments in 2023
Prediction 5: Despite Layoffs, Demand for Pharma IT Workforce to Account for Over 5% of the Total Pharma Workforce in Asia-Pacific in 2023
Country-specific Trends, 2023
India Snapshot
China Snapshot
Japan Snapshot
South Korea Snapshot
Australia Snapshot
Rest of Southeast Asia Snapshot
Growth Opportunity Universe
Growth Opportunity 1: Capability Expansion for Continuous Manufacturing in Asia-Pacific
Growth Opportunity 1: Capability Expansion for Continuous Manufacturing in Asia-Pacific (continued)
Growth Opportunity 2: Agile Partnership Models for Drug Discovery and Preclinical Drug Testing Services
Growth Opportunity 2: Agile Partnership Models for Drug Discovery and Preclinical Drug Testing Services (continued)
Growth Opportunity 3: Collaborations and R&D Investment in CGTs
Growth Opportunity 3: Collaborations and R&D Investment in CGTs (continued)
Conclusions
Key Conclusion